Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in WGS — GeneDx Holdings Corp.

CIK 923093 STAMFORD, CT

Position in WGS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,153,938
+$2,153,938 QoQ
Shares Held
33,540
Ownership
0.113%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 50.ToString("F0")% Shared 50.ToString("F0")% None 0.ToString("F0")%

Common Shares in WGS Over Time

Shares Held

Position Value (USD)

Derivatives in WGS

reported options exposure · as of Mar 31, 2026
CallValue
$687,154
CallShares
10,700
PutValue
$475,228
PutShares
7,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $196,413,250 across 21 Diagnostics & Research names. WGS ranks #12 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WGS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $687,154 10,700
2026-03-31 $475,228 7,400
2026-03-31 $2,153,938 33,540
2025-12-31 $234,108 1,800
2025-12-31 $949,438 7,300
2025-09-30 $7,396,781 68,654
2025-09-30 $592,570 5,500
2025-09-30 $1,109,722 10,300
2025-06-30 $655,401 7,100
2025-06-30 $2,169,285 23,500
2025-03-31 $701,523 7,921
2025-03-31 $212,556 2,400
2024-12-31 $7,825,116 101,810
2024-09-30 $2,577,211 60,726
2024-06-30 $2,391,470 91,487